Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Telephone Support for Metastatic Breast Cancer Patients [NA]
A completed trial evaluated telephone support for metastatic breast cancer patients, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: The Effects of a Nurse-led MHealth Program for Symptom Self-management of Breast Cancer Patients Undergoing Chemotherapy [NA]
A completed clinical trial evaluating a nurse-led mobile health program for symptom self-management in breast cancer patients undergoing che…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Massive Open Online Course (MOOC) for Women With Breast Cancer [NA]
The document reports the completion of a clinical trial evaluating a Massive Open Online Course (MOOC) for women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer [Phase 2, Phase 3]
A Phase 2/3 study evaluating the efficacy and safety of Inavolisib plus Palbociclib and Fulvestrant versus Placebo plus Palbociclib and Fulv…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer [Phase 2]
Phase 2 trial comparing alisertib plus paclitaxel versus paclitaxel alone in metastatic or locally recurrent breast cancer. Results have bee…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative Dose [NA]
Completed clinical trial evaluating cryoprotection to reduce nail toxicity from low cumulative-dose docetaxel in breast cancer patients; res…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: The Effect of Health Education on Breast Cancer [NA]
A completed clinical trial evaluating the impact of a health education program on individuals with breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone
A completed real-world study comparing palbociclib plus an aromatase inhibitor versus an aromatase inhibitor alone in premenopausal patients…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients [NA]
A completed clinical trial from the National Cancer Institute, Egypt, evaluating how neoadjuvant chemoradiation affects pathologic complete …
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor
A completed clinical trial reports positive estrogen receptor expression detected in metastatic breast cancer with ER-negative primary tumor…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Autologous Nerve Graft Breast Reconstruction Neurotization
ClinicalTrials.gov update notes an autologous nerve graft neurotization study for breast reconstruction in breast cancer patients. The trial…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.
A completed real-world study evaluating palbociclib plus letrozole as initial endocrine therapy in postmenopausal HR+/HER2- metastatic breas…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Observational Retrospective Study to Assess the Use of Ribociclib in Patients With HR+, HER2- Metastatic Breast Cancer Treated With Chemotherapy
A retrospective observational study evaluating the use of ribociclib in patients with HR-positive, HER2-negative metastatic breast cancer tr…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Cognitive Dysfunction and Breast Cancer Coping Strategies Impact on QOL [NA]
A completed clinical trial evaluating cognitive dysfunction in breast cancer patients and the impact of coping strategies on quality of life…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema [NA]
ClinicalTrials.gov notes a completed study comparing an adjustable compression wrap to a standard compression bandage for reducing breast ca…
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors [EARLY_Phase 1]
An early-phase window-of-opportunity trial assessed whether the PARP inhibitor rucaparib modulates PD-L1 expression in triple-negative breas…
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Diet Effect on Cancer Treatment Outcome [Phase 1]
A Phase 1 clinical trial evaluating the impact of diet on cancer treatment outcomes in breast and prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Patient Registry: Partial Breast Irradiation
Clinical trial NCT01127971, a patient registry studying partial breast irradiation for breast cancer, has been terminated. Sponsor: Wake For…
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer [Phase 1]
A Phase 1 crossover bioequivalence study comparing Olaparib 150 mg tablets from Lek Pharmaceuticals with Lynparza 150 mg tablets in BRCA-mut…
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Effects of Yoga on Women with Breast Cancer [NA]
This completed clinical trial from The Hong Kong Polytechnic University evaluated the effects of yoga on upper limb function, sleep quality,…
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Exercise in Older Women With Breast Cancer During Systemic Therapy [NA]
A completed clinical trial evaluated exercise in older women with breast cancer undergoing systemic therapy. No results are reported in this…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Effect of Adding Dexmedetomidine As Adjuvant to Bupivacaine in US Guided ESPB for Post MRM Pain Management [NA]
This clinical trial evaluated whether adding dexmedetomidine to bupivacaine for an ultrasound-guided erector spinae plane block improves pos…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
An update on a completed clinical trial investigating imaging markers of subclinical cardiotoxicity in breast cancer. The study aimed to ide…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer [EARLY_Phase 1]
Early-phase trial update evaluating the cartilage-targeting tracer 99mTc-NTP 15-5 in patients with osteoarthritis of the knee and breast can…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study). [Phase 4]
Phase IV randomized study comparing palbociclib plus endocrine therapy to a chemotherapy-based strategy in HR-positive/HER2-negative metasta…